Ken Galbraith

Ken Galbraith

Chief Executive Officer chez ZYMEWORKS INC.

Fortune : 249 976 $ au 31/03/2024

61 ans
Health Technology
Commercial Services
Finance

Provenance du réseau au premier degré de Ken Galbraith

EntitéType d'entitéIndustrie
University of British Columbia
353
College/University Other Consumer Services 353
39
Subsidiary Biotechnology 39
27
Subsidiary Investment Managers 27
Public Company Pharmaceuticals: Major 27
Public Company Pharmaceuticals: Major 27
22
Extinct Miscellaneous Commercial Services 22
Public Company Biotechnology 21
Public Company Pharmaceuticals: Major 17
Public Company Medical Specialties 16
10
Extinct Pharmaceuticals: Major 10
9
Holding Company Packaged Software 9
8
Subsidiary Biotechnology 8
8
Private Company Investment Managers 8
Mutual Fd-Closed End Investment Trusts/Mutual Funds 5
2
Holding Company Medical Specialties 2
1
Subsidiary Miscellaneous Commercial Services 1
1
Private Company Investment Managers 1

Graphique Sociétés connectées au second degré

Relation dans plusieurs entreprises

Sociétés connectées à Ken Galbraith via son réseau personnel

SociétéSecteurPersonnes liéesPoste principal
Chemicals: Agricultural

Arnold Lewis Oronsky

Robert Obst

Corporate Officer/Principal

Corporate Officer/Principal

BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Bruce Wendel

Susan Mahony

Mark Hollywood

Karen Ferrante

Michael McElhaugh

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Medical Specialties

Scott Jackson

Derek Miller

Corporate Officer/Principal

Corporate Officer/Principal

Biotechnology

David Stump

Kenneth Hillan

Stanford J. Stewart

Troy Cox

Derek Miller

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Corporate Officer/Principal

Sales & Marketing

Corporate Officer/Principal

JOHNSON & JOHNSON Pharmaceuticals: Major

Paulo Costa

David Jeans

Jay Siegel

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

ELI LILLY AND COMPANY Pharmaceuticals: Major

Susan Mahony

Scott Jackson

Stephen Eck

Director/Board Member

Corporate Officer/Principal

Corporate Officer/Principal

Medical Specialties

David Stump

Thomas Spitznagel

Paul Moore

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Corporate Officer/Principal

QUEBECOR INC. Cable/Satellite TV

Pierre Laurin

Louise Ménard

Director/Board Member

General Counsel

Biotechnology

Arnold Lewis Oronsky

Stanford J. Stewart

Director/Board Member

Chief Tech/Sci/R&D Officer

PORTOLA PHARMACEUTICALS, INC. Pharmaceuticals: Major

David Stump

Hollings Renton

Director/Board Member

Chairman

CELATOR PHARMACEUTICALS INC Pharmaceuticals: Major

Scott Jackson

Derek Miller

Chief Executive Officer

Corporate Officer/Principal

Miscellaneous Commercial Services

Hollings Renton

Jeffrey Peters

Jay Siegel

Director/Board Member

Corporate Officer/Principal

Director/Board Member

Investment Managers

Kelly Holman

Damian Lamb

Private Equity Investor

Private Equity Investor

Stanford University College/University

Eric Risser

Jay Siegel

Masters Business Admin

Doctorate Degree

University of Oxford College/University

Stuart J. M. Collinson

Martin Murphy

Alex Hamilton

Doctorate Degree

Undergraduate Degree

Graduate Degree

XENON PHARMACEUTICALS INC. Pharmaceuticals: Major

Michael Hayden

Gary Bridger

Wajida Leclerc

Founder

Chief Tech/Sci/R&D Officer

Human Resources Officer

University of Cambridge College/University

Martin Murphy

Chris Hollowood

Alex Hamilton

Doctorate Degree

Doctorate Degree

Doctorate Degree

Packaged Software

Mark Fowlie

Kevin Kimsa

Corporate Officer/Principal

Founder

McGill University College/University

Raymond M. Hakim

Kurt Stefan Victor Clulow

Samira Sakhia

Doctorate Degree

Graduate Degree

Corporate Officer/Principal

ALLON THERAPEUTICS INC. Pharmaceuticals: Major

Anthony G. Phillips

Jim J. Miller

Samira Sakhia

Director/Board Member

Chairman

Director/Board Member

Massachusetts Institute of Technology College/University

Raymond M. Hakim

Michael Jeffrey Abrams

Thomas Spitznagel

Doctorate Degree

Doctorate Degree

Undergraduate Degree

Queen's University of Belfast College/University

Kelly Holman

Damian Lamb

Masters Business Admin

Masters Business Admin

Indiana University College/University

David Stump

Arthur M. Bruskin

Bill Adams

Carlos Campoy

Doctorate Degree

Doctorate Degree

Graduate Degree

Masters Business Admin

College/University

Michael Steinmetz

Jay Siegel

Corporate Officer/Principal

Undergraduate Degree

Princeton University College/University

Donald Lee Drakeman

Kelvin Neu

Doctorate Degree

Undergraduate Degree

Simon Fraser University College/University

Terry Hamilton

David Matousek

Wajida Leclerc

Masters Business Admin

Undergraduate Degree

Undergraduate Degree

University of Toronto College/University

Mark Fowlie

Alek Krstajic

Eugene Siklos

Paul Mesburis

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

The University of Waterloo College/University

Kevin Kimsa

Kris Shah

Director/Board Member

Undergraduate Degree

University of Western Ontario College/University

Nancy Orr

Anthony G. Phillips

Jim J. Miller

Undergraduate Degree

Doctorate Degree

Doctorate Degree

University of Montréal College/University

Pierre Laurin

Louise Ménard

Marie Iskra

Graduate Degree

Graduate Degree

Graduate Degree

APPLIED GENETIC TECHNOLOGIES CORPORATION Pharmaceuticals: Generic

Arnold Lewis Oronsky

Chris Hollowood

Director/Board Member

Director/Board Member

London School of Economics & Political Science College/University

Martin MacLachlan

Alice Renard

Graduate Degree

Graduate Degree

University College London College/University

Rolf Soderstrom

Lisa Bright

Undergraduate Degree

Undergraduate Degree

Investment Managers

Anthony G. Phillips

Jim J. Miller

Founder

Chief Executive Officer

ALDER BIOPHARMACEUTICALS, INC. Pharmaceuticals: Major

Gary Bridger

Carlos Campoy

Christopher Astle

Director/Board Member

Director of Finance/CFO

Corporate Officer/Principal

Pharmaceuticals: Major

Michael Steinmetz

Martin Murphy

Founder

Director/Board Member

Financial Conglomerates

Louise Ménard

Marie Iskra

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

Brian Leeners

Jennifer Kaufman-Shaw

Martin MacLachlan

Daniel Dex

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Biotechnology

Chris Hollowood

Roel Bulthuis

Director/Board Member

Director/Board Member

Harvard Business School College/University

Stuart J. M. Collinson

Paulo Costa

Eugene Siklos

Masters Business Admin

Masters Business Admin

Masters Business Admin

FUSN PHAR Pharmaceuticals: Major

Damian Lamb

Eran Nadav

Chairman

Director/Board Member

NERVGEN PHARMA CORP. Pharmaceuticals: Major

Michael Jeffrey Abrams

Bill Adams

Director/Board Member

Director of Finance/CFO

Biotechnology

Martin Murphy

Alex Hamilton

Chairman

Director/Board Member

Miscellaneous Commercial Services

Martin Murphy

Lisa Bright

Director/Board Member

Chairman

Miscellaneous Commercial Services

Chris Hollowood

Michael Kyriakides

Chairman

Director/Board Member

Statistiques

Internationale

Etats-Unis 24
Canada 19
Royaume-Uni 9
Suisse 2

Sectorielle

Health Technology 24
Consumer Services 18
Commercial Services 5
Finance 5
Process Industries 2

Opérationnelle

Director/Board Member 499
Corporate Officer/Principal 212
Independent Dir/Board Member 130
Chairman 87
Undergraduate Degree 73
  1. Bourse
  2. Insiders
  3. Ken Galbraith
  4. Connexions Sociétés